This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignee: The University of British Columbia. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2025
Title: Georgia Elizabeth Mewis: Innovator in Lymphocyte Receptor Research
Introduction
Georgia Elizabeth Mewis is a prominent inventor based in Vancouver, Canada. She has made significant contributions to the field of immunology, particularly in the study of lymphocyte receptor chains. With a total of 3 patents to her name, Mewis is recognized for her innovative approaches to understanding immune responses.
Latest Patents
Mewis's latest patents focus on high-throughput sequencing methods for determining lymphocyte receptor chain pairs. These methods are designed to study the diversity and functionality of lymphocyte receptor chains. Specifically, her patents provide techniques to confidently identify one or more functional lymphocyte receptor chain pairs in a sample. This advancement is crucial for enhancing our understanding of immune system functionality.
Career Highlights
Georgia Elizabeth Mewis is affiliated with the University of British Columbia, where she conducts her research. Her work has garnered attention for its potential applications in immunotherapy and disease treatment. Mewis's dedication to her field is evident in her innovative research and the impact it has on advancing scientific knowledge.
Collaborations
Mewis collaborates with esteemed colleagues, including Carl Lars Genghis Hansen and Kevin Albert Heyries. These partnerships enhance her research capabilities and contribute to the success of her projects.
Conclusion
Georgia Elizabeth Mewis is a trailblazer in the field of lymphocyte receptor research. Her innovative patents and collaborative efforts position her as a key figure in advancing immunological studies. Her contributions are paving the way for future breakthroughs in understanding immune responses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
